C.Uyemura & Co Ltd
TSE:4966
US |
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
|
US |
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
|
US |
Bank of America Corp
NYSE:BAC
|
Banking
|
|
US |
Mastercard Inc
NYSE:MA
|
Technology
|
|
US |
Abbvie Inc
NYSE:ABBV
|
Biotechnology
|
|
US |
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
|
US |
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
|
US |
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
|
US |
Visa Inc
NYSE:V
|
Technology
|
|
CN |
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
|
US |
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
|
US |
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
|
US |
Coca-Cola Co
NYSE:KO
|
Beverages
|
|
US |
Realty Income Corp
NYSE:O
|
Real Estate
|
|
US |
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
|
US |
Walt Disney Co
NYSE:DIS
|
Media
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
This note will be permanently deleted.
C.Uyemura & Co Ltd
Other Equity
C.Uyemura & Co Ltd
Other Equity Peer Comparison
Competitive Other Equity Analysis
Latest Figures & CAGR of Competitors
Company | Other Equity | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
C.Uyemura & Co Ltd
TSE:4966
|
Other Equity
ÂĄ10.9B
|
CAGR 3-Years
63%
|
CAGR 5-Years
32%
|
CAGR 10-Years
18%
|
|
Nitto Denko Corp
TSE:6988
|
Other Equity
ÂĄ122.5B
|
CAGR 3-Years
123%
|
CAGR 5-Years
58%
|
CAGR 10-Years
21%
|
|
JSR Corp
TSE:4185
|
Other Equity
ÂĄ70.6B
|
CAGR 3-Years
66%
|
CAGR 5-Years
30%
|
CAGR 10-Years
26%
|
|
Kansai Paint Co Ltd
TSE:4613
|
Other Equity
ÂĄ10.2B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Nippon Paint Holdings Co Ltd
TSE:4612
|
Other Equity
ÂĄ423.4B
|
CAGR 3-Years
114%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Shin-Etsu Chemical Co Ltd
TSE:4063
|
Other Equity
ÂĄ474B
|
CAGR 3-Years
N/A
|
CAGR 5-Years
141%
|
CAGR 10-Years
50%
|
See Also
What is C.Uyemura & Co Ltd's Other Equity?
Other Equity
10.9B
JPY
Based on the financial report for Mar 31, 2024, C.Uyemura & Co Ltd's Other Equity amounts to 10.9B JPY.
What is C.Uyemura & Co Ltd's Other Equity growth rate?
Other Equity CAGR 10Y
18%
Over the last year, the Other Equity growth was 32%. The average annual Other Equity growth rates for C.Uyemura & Co Ltd have been 63% over the past three years , 32% over the past five years , and 18% over the past ten years .